These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6183945)

  • 41. Direct cell-mediated cytotoxicity in experimental allergic encephalomyelitis.
    Eggers AE; Hibbard CA
    J Neurol Sci; 1981 Jan; 49(1):109-16. PubMed ID: 6162919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to the encephalitogenic determinant in inbred guinea pigs.
    Teitelbaum D; Webb C; Arnon R; Sela M
    Cell Immunol; 1977 Mar; 29(2):265-71. PubMed ID: 67899
    [No Abstract]   [Full Text] [Related]  

  • 43. Modulation of the immunologic response of myelin basic protein by extrinsic and intrinsic factors.
    Nagai Y
    Neurology; 1976 Jun; 26(6 PT 2):45-6. PubMed ID: 58395
    [No Abstract]   [Full Text] [Related]  

  • 44. Experimental allergic encephalomyelitis-inducing activity of synthetic polyadenylic and polyuridylic homopolymers and complexes in guinea pigs.
    Paterson PY
    Cell Immunol; 1976 Jan; 21(1):48-55. PubMed ID: 55310
    [No Abstract]   [Full Text] [Related]  

  • 45. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
    Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
    J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
    Jewell SD; Gienapp IE; Cox KL; Whitacre CC
    Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-encephalitogenic synthetic analogues of the determinant for allergic encephalomyelitis in guinea pigs.
    Hashim GA; Sharpe RD
    Nature; 1975 Jun; 255(5508):484-5. PubMed ID: 49022
    [No Abstract]   [Full Text] [Related]  

  • 49. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaccination against experimental autoimmune diseases using T lymphocytes treated with hydrostatic pressure.
    Lider O; Shinitzky M; Cohen IR
    Ann N Y Acad Sci; 1986; 475():267-73. PubMed ID: 2431645
    [No Abstract]   [Full Text] [Related]  

  • 51. Hyperacute autoimmune encephalomyelitis induced by a synthetic autoantigen.
    Westall FC; Thompson M; Lennon VA
    Nature; 1977 Sep; 269(5627):425-7. PubMed ID: 71663
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral tolerance in autoimmune encephalomyelitis. In vivo reversal of anergy.
    Gienapp I; Cox K; Javed N; Whitacre C
    Ann N Y Acad Sci; 1996 Feb; 778():382-3. PubMed ID: 8610997
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunology cross-reactivity between spinal cord protein and myelin basic protein.
    Ramshaw IA; Welter D; MacPherson CF
    Int Arch Allergy Appl Immunol; 1982; 68(3):196-200. PubMed ID: 6177644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In healthy primates, circulating autoreactive T cells mediate autoimmune disease.
    Genain CP; Lee-Parritz D; Nguyen MH; Massacesi L; Joshi N; Ferrante R; Hoffman K; Moseley M; Letvin NL; Hauser SL
    J Clin Invest; 1994 Sep; 94(3):1339-45. PubMed ID: 7521889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allergic encephalomyelitis induced in guinea pigs by a peptide from the NH2-terminus of bovine P2 protein.
    Brostoff SW; Powers JM; Weise MJ
    Nature; 1980 May; 285(5760):103-4. PubMed ID: 6154892
    [No Abstract]   [Full Text] [Related]  

  • 57. MBP-specific experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R
    J Immunol; 2004 Jul; 173(1):5; author reply 5-6. PubMed ID: 15210750
    [No Abstract]   [Full Text] [Related]  

  • 58. Experimental allergic encephalomyelitis in suckling Lewis rats: comparison with the disease in adult animals.
    Dal Canto MC; Fujinami RS; Paterson PY
    Lab Invest; 1977 Oct; 37(4):395-405. PubMed ID: 71391
    [No Abstract]   [Full Text] [Related]  

  • 59. Reactive and nonreactive lymphocytes in experimental allergic encephalomyelitis. I. Possible role of macrophage-lymphocyte interactions.
    Lisak RP; Zweiman B; Levinson AI
    Int Arch Allergy Appl Immunol; 1976; 51(2):253-64. PubMed ID: 58839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A suppressor cell line that prevents the adoptive transfer of EAE in Lewis rats.
    Ellerman K; Brostoff S
    Ann N Y Acad Sci; 1988; 540():364-6. PubMed ID: 2462813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.